Pharmaceutical Contract Packaging Market Size, Share & Analysis Report By Packaging Type (Primary, Secondary, Tertiary), By Material (Plastics, Paper & Paperboard, Glass, Aluminum Foil), By Region, And Segment Forecasts, 2025 - 2033

Pharmaceutical Contract Packaging Market Summary

The global pharmaceutical contract packaging market size was estimated at USD 33.87 billion in 2024 and is anticipated to reach USD 55.78 billion by 2033, growing at a CAGR of 5.8% from 2025 to 2033. Growth outlook is driven by the increasing trend of outsourcing packaging operations to specialized contract packaging companies.

Facing pressure to cut costs and increase operational efficiency, pharmaceutical companies find outsourcing an effective solution. By partnering with packaging suppliers, they can focus on their core activities, such as drug discovery and development, leaving behind complex packaging, including compliance with regulatory requirements and managing new packaging for outside experts.

Another key factor driving the market's growth is the demand for customized, complex packaging products such as biologics, biosimilars, and personalized medicines that require specialized packaging. For instance, biologics and injectables often require temperature-controlled, sterile, non-deformable packaging to ensure packaging stability and safety. Contract packaging suppliers have increasingly deployed the technical capabilities and resources to handle these complex packaging requirements, ensuring that pharmaceutical companies deliver quality to consumers while meeting stringent regulatory standards.

Moreover, pharmaceutical products are subject to safety regulations, such as serialization requirements for traceability and compliance with Good Manufacturing Practices (GMP), ensuring that packaging adheres to the specific guidelines of regulatory bodies such as the FDA, EMA, and other regional agencies. Since packaging is critical to drug safety and counterfeit assurance, pharmaceutical companies have increasingly relied on experienced contract packagers to meet these evolving regulatory requirements and drive overall market expansion.

The growth of biopharmaceuticals and personalized medicine is another factor linking pharmaceutical industry expansion to packaging demand. Biologics and advanced therapies such as cell and gene therapies often require highly specialized packaging environments, including cold chain logistics and sterile containment. Contract packagers with expertise in temperature-controlled packaging, lyophilized product packaging, and prefilled syringes are increasingly sought after. For example, companies such as PCI Pharma Services and Catalent have expanded their facilities to support biologics packaging, reflecting the growing need for customized solutions aligned with pharmaceutical innovation trends.

Moreover, the globalization of pharmaceutical production and distribution magnifies the importance of contract packaging. With cross-border supply chains and rising exports of medicines from countries like India (the world’s largest supplier of generics) and China (a major API and formulation producer), packaging must meet diverse international regulatory standards such as FDA, EMA, and MHRA guidelines. Contract packagers act as strategic partners by offering multi-market compliant packaging and serialization services, enabling pharmaceutical companies to enter new geographies efficiently. This global expansion of the pharmaceutical industry, therefore, directly translates into sustained growth opportunities for contract packaging providers.

Global Pharmaceutical Contract Packaging Market Report Segmentation

This report forecasts revenue growth at a global level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global pharmaceutical contract packaging market report based on material, packaging type, and region:

• Material Outlook (Revenue, USD Million, 2021 - 2033)
• Plastic
• Paper & Paperboard
• Glass
• Aluminum Foil
• Others
• Packaging Type Outlook (Revenue, USD Million, 2021 - 2033)
• Primary Packaging
• Bottles
• Vials
• Ampoules
• Blister Packs
• Others
• Secondary Packaging
• Tertiary Packaging
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
• U.S.
• Canada
• Mexico
• Europe
• Germany
• France
• UK
• Italy
• Spain
• Sweden
• Denmark
• Norway
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• Latin America
• Brazil
• Argentina
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE

Please note The report will be delivered in 4-8 business days upon order notification. Show more